COMFORT, SUSTAINABILITY & TIMELESS APPEAL BOSS DESIGN LAUNCHES REMI, FRIDA & MEWS IN THE USA
HIGH POINT, N.C., June 10, 2024 /PRNewswire/ — Boss Design continues its mission to turn workplaces into destination spaces across the…
Brand Post
We Are There: Awareness campaign launches to promote life-giving work of Catholic Charities agencies
ALEXANDRIA, Va., June 10, 2024 /PRNewswire/ — Catholic Charities USA (CCUSA), the national membership organization for Catholic Charities agencies, has…
Canadian Investment Regulatory Organization Trade Resumption – YORK
VANCOUVER, BC, June 10, 2024 /CNW/ – Trading resumes in: Company: York Harbour Metals Inc. TSX-Venture Symbol: YORK All Issues:…
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Nvidia BioNeMo generative AI platform will be used to accelerate the training of models on proprietary data NEW YORK, June…
The Central America Bottling Corporation Commences Consent Solicitation
BRITISH VIRGIN ISLANDS, June 10, 2024 /PRNewswire/ — The Central America Bottling Corporation (the “Company“) today announced that the Company,…
GORTON’S SEAFOOD MARKS 175TH ANNIVERSARY WITH NATIONWIDE CELEBRATION: YELLOW, OUT OF THE BLUE
Gorton’s community is spreading kindness with 175 acts of joy GLOUCESTER, Mass., June 10, 2024 /PRNewswire/ — It’s time to…
J INTS BIO, ASCO 2024 – JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
SEOUL, South Korea, June 10, 2024 /PRNewswire/ — J INTS BIO provided an update of its ongoing Phase 1 clinical…
DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)
SEOUL, South Korea, June 10, 2024 /PRNewswire/ — DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic…
Build-A-Bear Celebrates International Day of Play with ‘The Stuff You Love’: Free Lil Cub Bears, Heartwarming Donations and Fun for Kids
Experience the Magic of Play with Build-A-Bear’s Heartfelt Initiatives ST. LOUIS, June 10, 2024 /PRNewswire/ — Build-A-Bear Workshop, Inc. (NYSE:…
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., June 9, 2024 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc.…
↑